Fraud Happens: What to Do About It

For many years physicists lagged way behind biologists in the perpetration of scientific fraud. But they have caught up in spectacular style with the ambitious opus of Jan Henrik Schon of Bell Labs, who placed seven of his fictive works in Nature and nine in Science. All those ad hoc explanations for biomedicine's leadership role in fraud--that entrance to medical school selected for corner-cutters, or that the mathematical structure of physics leaves little slack for fudging figures--must be

Written byNicholas Wade
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For many years physicists lagged way behind biologists in the perpetration of scientific fraud. But they have caught up in spectacular style with the ambitious opus of Jan Henrik Schon of Bell Labs, who placed seven of his fictive works in Nature and nine in Science. All those ad hoc explanations for biomedicine's leadership role in fraud--that entrance to medical school selected for corner-cutters, or that the mathematical structure of physics leaves little slack for fudging figures--must be laid aside.

Fraud in science is a minor irritant from one perspective, a serious problem from another. Most instances of fraud concern work of little importance and are quickly forgotten. Some practitioners forsake the safety of mundane fabrication and concoct spectacular experiments about matters at the cutting edge of their fields. But one can argue that the more ambitious the fraud, the more quickly it will be discovered.

The Schon case does ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies